Editorial ArticleClinical Diagnostics
AI and the rise of blood-based biomarkers heralds new era for neurological diagnostics
Quanterix Director of Medical Affairs discusses the advances revolutionizing Alzheimer’s diagnosis and care
View articleNews & Articles
25
Best match
Editorial ArticleClinical Diagnostics
Dried blood spot testing is revolutionizing Alzheimer’s monitoring
Discover how advances in dried blood spot testing are advancing biomarker analysis and sample collection
View article
Product NewsLife Sciences
Quanterix launches novel p-Tau 205 and p-Tau 212 assays to advance Alzheimer’s research at AAIC
Company highlights expanded capabilities following Akoya Biosciences Acquisition and Simoa technology included in more than 55 posters and oral presentations at the annual conference demonstrating its impact on neurodegenerative disease research
View article
Editorial ArticleDrug Discovery & Development
Simoa Technology aims to transform future Alzheimer's disease detection and treatment
Learn how biomarkers can be used to transform drug approval and patient management in neurodegenerative medicine
View article